Redpulse

$NVO BREAKING: Novo Nordisk's trial drug zenagamtide for obesity beat expectations for phase 2 results and is moving to phase 3. "Novo Nordisk’s investigational zenagamtide shows significant HbA1C reductions with up to 14.6% weight loss in adults with type 2 diabetes - presented at ADA 2026" novonordisk.com/content/nncorp…

Good for $NVO: -2% Bad for $NVO: -5%

@pennystockabe 100% agree, NVO is my favorite

@Redpulse_News Novo has most potential with oral semag. theyare destroy LLy in the oral pill market. Now they have Wegovy Pill Ozempic Pill Rybelsus Pill Eli Lly lives in the injectable mkt. The world wants a pill form and Novo has the solution.

Which is your favorite: $SOFI at $17 $NVO at $44 $ZETA at $20 $META at $567 $NVDA at $205

@LazaroInvestor Very cheap right now

@Redpulse_News $META

@Dboybruh The valuation is ridiculous

@Redpulse_News SoFi

@NadavZur My choice!

@Redpulse_News NVO

@pennystockabe $META owns years, decades for some people, of search history from its users. It knows everything about everyone who uses its platform. It owns the LLaMA model which personalizes advertisements and increases efficiency for its clients, which can turn into even greater adspend.

@Redpulse_News Not Meta which is just facebook and little else. That whole company csn be copied by AI and lives in Apples hand devices. For $500B sure. $1.5T ? (almost same as AMZN, MSFT, GOOGL) no thx.

@nip1007 Respectable. It’s very cheap right now

@Redpulse_News Nvda. No question about it

$NVO NEWS: the chart has been updated. Novo hit a new record in weekly prescriptions filled. I'm told the decline two weeks ago was due to a 4-day week.

.@Aktieland saw it first, but $NVO is forming a cup and handle pattern. Target is $59.11 USD. The solid blue vertical line is next earnings which should be a catalyst.

@Aktieland Yes you're right! And the target should be just short of 375 DKK as you said. But this is only the beginning.

Could $NVO be forming a Cup & Handle? A breakout above ~300 DKK would be the key confirmation signal. Measured target? Roughly 365-375 DKK. One step at a time, but the setup is worth watching. #TechnicalAnalysis #NVO

@Aktieland Hold on… let me draw something up and see

@Eddie_Pakbayram And which one is expanding in Europe vs contracting…

@Redpulse_News Just checked number of employees. Lily has half as much of Novo

Wegovy pill was just approved in UK and somehow $LLY is up more than $NVO 😂 $LLY by itself is a bigger bubble than the entire AI sector.

@keailv @JacobCordosa Accurate 😡

@Redpulse_News I always keep this cheat sheet from @JacobCordosa around.

@Aktieland I like your name by the way, perfect for 🇩🇰

One potential catalyst for $NVO: Every time Oral #Wegovy enters a new market, a new pool of investors starts paying attention to $NVO. I see growing interest from #UK investors here on X. They see the demand, the opportunity, and the value gap.

@Aktieland Maybe, just maybe… we can get a fair valuation multiple by the time Wegovy goes global

@Andersanden Great to hear!!!

@Redpulse_News I am all 50% in

I am doubling down on $NVO. I just sold half of my entire non-NVO portfolio. I am increasing my position in Novo Nordisk by 40%. Novo is the king of GLP1s. $LLY will fall from the top spot, and the fall will be much worse because they're trading at QUADRUPLE the P/E of $NVO.

@Mayflysky I love it!!!

@Redpulse_News I’m 90% position on $NVO. Fly or die

@TommyDeng17 Yes I do. That’s why I’m buying $NVO

@Redpulse_News Do u not care about earnings growth?